Manufacturer Removes Remaining Stocks Of Trasylol
Background: On Nov. 5, 2007, the U.S. Food and Drug Administration announced that Bayer Pharmaceuticals Corp. agreed to an FDA-requested marketing suspension of Trasylol, a drug used to control bleeding during heart surgery. At that time, preliminary results from a Canadian study suggested an increased risk for death compared to two other drugs used to control bleeding. Bayer HealthCare Pharmaceuticals Inc.
More: continued here
Filed under: Blood on May 17th, 2008